Pfizer-BioNTech says Covid-19 vaccine is safe, effective on adolescents

  • 📰 trtworld
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

BioNTech and Pfizer say their Covid-19 vaccine trials showed 100 percent efficacy in 12- to 15-year-olds, as they eye approval for adolescents to get the jabs before the next school year

Phase 3 trials carried out on 2,260 adolescents in the US"demonstrated 100 percent efficacy and robust antibody responses," the companies say.

Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses", the companies said in a statement on Wednesday. A younger cohort of two-to-five year olds are expected to get their first dose next week in the study which will also cover children as young as six months old.Production increase

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Çocuklar için gerek var mı?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ongoing trial shows Pfizer Covid-19 vaccine remains highly effective after six monthsThe ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The trial continues and protection is expected to last longer than six months. When are they gonna make measles, mumps and rubella vaxxes only last for 6 months? Chicken pox? They kept that a secret six months poor quality vaccine Only 6 months. Scared of needles
Source: cnnbrk - 🏆 393. / 55 Read more »